Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Air Lease A | AL | 21. nov 2024 | 49.80 | +3.92 |
Air Lease Pref A | AL-A | 21. nov 2024 | 25.18 | 0.00 |
Air Products And Chemicals | APD | 21. nov 2024 | 328.88 | +0.31 |
Air T | AIRTP | 21. nov 2024 | 17.35 | +1.39 |
Air T | AIRT | 21. nov 2024 | 18.32 | +5.96 |
Air Transport Services Group | ATSG | 21. nov 2024 | 21.96 | -0.14 |
Airbnb A | ABNB | 21. nov 2024 | 133.26 | -1.47 |
Airgain | AIRG | 21. nov 2024 | 8.58 | +1.06 |
AirNet Technology ADR | ANTE | 21. nov 2024 | 0.49 | +4.22 |
AirSculpt Technologies | AIRS | 21. nov 2024 | 6.78 | +6.77 |
Airship AI A | AISP | 21. nov 2024 | 2.44 | -4.69 |
AIX ADR | AIFU | 21. nov 2024 | 1.25 | 0.00 |
Akamai Technologies | AKAM | 21. nov 2024 | 91.08 | +3.55 |
Akanda | AKAN | 21. nov 2024 | 1.34 | -2.19 |
Akari Therapeutics ADR | AKTX | 21. nov 2024 | 1.24 | -15.65 |
Akebia Therapeutics | AKBA | 21. nov 2024 | 1.82 | +1.68 |
Akero Therapeutics | AKRO | 21. nov 2024 | 31.20 | +1.84 |
Akoustis Technologies | AKTS | 21. nov 2024 | 0.10 | +19.86 |
Akoya BioSciences | AKYA | 21. nov 2024 | 2.12 | -1.85 |
Akso Health ADR | AHG | 21. nov 2024 | 0.88 | +0.06 |
Alamo Group | ALG | 21. nov 2024 | 196.36 | +2.41 |
Alamos Gold | AGI | 21. nov 2024 | 18.86 | +0.80 |
Alarm.com | ALRM | 21. nov 2024 | 60.78 | +0.96 |
Alarum Technologies ADR | ALAR | 21. nov 2024 | 13.29 | +6.15 |
Alaska Air Group | ALK | 21. nov 2024 | 52.30 | -1.58 |
Alaunos Therapeutics | TCRT | 21. nov 2024 | 2.32 | +8.92 |
Albany International | AIN | 21. nov 2024 | 82.53 | -1.23 |
Albemarle | ALB | 21. nov 2024 | 108.98 | -0.52 |
Albemarle ADR A Pref | ALB-A | 21. nov 2024 | 49.11 | -0.65 |
Albertsons Companies A | ACI | 21. nov 2024 | 19.06 | -0.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.